Literature DB >> 32936422

Neutral ceramidase is a marker for cognitive performance in rats and monkeys.

Liubov S Kalinichenko1, An-Li Wang2, Christiane Mühle1, Joseph P Huston2, Laila Abdel-Hafiz2, Erich Gulbins3,4, Johannes Kornhuber1, André W C Oliveira5, Marilia Barros5,6, Christian P Müller7.   

Abstract

BACKGROUND: Ceramides are lipid molecules determining cell integrity and intercellular signaling, and thus, involved in the pathogenesis of several psychiatric and neurodegenerative disorders. However, little is known about the role of particular enzymes of the ceramide metabolism in the mechanisms of normal behavioral plasticity. Here, we studied the contribution of neutral ceramidase (NC), one of the main enzymes mediating ceramide degradation, in the mechanisms of learning and memory in rats and non-human primates.
METHODS: Naïve Wistar rats and black tufted-ear marmosets (Callithrix penicillata) were tested in several tests for short- and long-term memory and then divided into groups with various memory performance. The activities of NC and acid ceramidase (AC) were measured in these animals. Additionally, anxiety and depression-like behavior and brain levels of monoamines were assessed in the rats.
RESULTS: We observed a predictive role of NC activity in the blood serum for superior performance of long-term object memory tasks in both species. A brain area analysis suggested that high NC activity in the ventral mesencephalon (VM) predicts better short-term memory performance in rats. High NC activity in the VM was also associated with worse long-term object memory, which might be mediated by an enhanced depression-like state and a monoaminergic imbalance.
CONCLUSIONS: Altogether, these data suggest a role for NC in short- and long-term memory of various mammalian species. Serum activity of NC may possess a predictive role in the assessing the performance of certain types of memory.

Entities:  

Keywords:  Ceramide; Memory; Neutral ceramidase; Non-human primates; Rats; Ventral mesencephalon

Year:  2020        PMID: 32936422      PMCID: PMC7862079          DOI: 10.1007/s43440-020-00159-2

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  57 in total

Review 1.  The ceramide system as a novel antidepressant target.

Authors:  Johannes Kornhuber; Christian P Müller; Katrin Anne Becker; Martin Reichel; Erich Gulbins
Journal:  Trends Pharmacol Sci       Date:  2014-05-01       Impact factor: 14.819

Review 2.  The role of sphingolipids in psychoactive drug use and addiction.

Authors:  Liubov S Kalinichenko; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  J Neural Transm (Vienna)       Date:  2018-01-10       Impact factor: 3.575

3.  High activity of acid sphingomyelinase in major depression.

Authors:  J Kornhuber; A Medlin; S Bleich; V Jendrossek; A W Henkel; J Wiltfang; E Gulbins
Journal:  J Neural Transm (Vienna)       Date:  2005-11       Impact factor: 3.575

4.  Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients.

Authors:  Martin Reichel; Johannes Beck; Christiane Mühle; Andrea Rotter; Stefan Bleich; Erich Gulbins; Johannes Kornhuber
Journal:  Alcohol Clin Exp Res       Date:  2011-05-19       Impact factor: 3.455

Review 5.  The organizing potential of sphingolipids in intracellular membrane transport.

Authors:  J C Holthuis; T Pomorski; R J Raggers; H Sprong; G Van Meer
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

Review 6.  Raft ceramide in molecular medicine.

Authors:  Erich Gulbins; Richard Kolesnick
Journal:  Oncogene       Date:  2003-10-13       Impact factor: 9.867

7.  Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs.

Authors:  Erich Gulbins; Monica Palmada; Martin Reichel; Anja Lüth; Christoph Böhmer; Davide Amato; Christian P Müller; Carsten H Tischbirek; Teja W Groemer; Ghazaleh Tabatabai; Katrin A Becker; Philipp Tripal; Sven Staedtler; Teresa F Ackermann; Johannes van Brederode; Christian Alzheimer; Michael Weller; Undine E Lang; Burkhard Kleuser; Heike Grassmé; Johannes Kornhuber
Journal:  Nat Med       Date:  2013-06-16       Impact factor: 53.440

8.  Sex-dependent decrease of sphingomyelinase activity during alcohol withdrawal treatment.

Authors:  Christiane Mühle; Violina Amova; Teresa Biermann; Kristina Bayerlein; Tanja Richter-Schmidinger; Thomas Kraus; Martin Reichel; Erich Gulbins; Johannes Kornhuber
Journal:  Cell Physiol Biochem       Date:  2014-06-16

Review 9.  Lipids in psychiatric disorders and preventive medicine.

Authors:  Miriam Schneider; Beth Levant; Martin Reichel; Erich Gulbins; Johannes Kornhuber; Christian P Müller
Journal:  Neurosci Biobehav Rev       Date:  2016-06-16       Impact factor: 8.989

10.  Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasis.

Authors:  Christian P Müller; Liubov S Kalinichenko; Jens Tiesel; Matthias Witt; Thomas Stöckl; Eva Sprenger; Jens Fuchser; Janine Beckmann; Marc Praetner; Sabine E Huber; Davide Amato; Christiane Mühle; Christian Büttner; Arif B Ekici; Irena Smaga; Lucyna Pomierny-Chamiolo; Bartosz Pomierny; Malgorzata Filip; Volker Eulenburg; Erich Gulbins; Anbarasu Lourdusamy; Martin Reichel; Johannes Kornhuber
Journal:  Acta Neuropathol       Date:  2016-12-20       Impact factor: 17.088

View more
  2 in total

1.  Spontaneous object recognition in capuchin monkeys: assessing the effects of sex, familiarization phase and retention delay.

Authors:  Jéssica Aquino; Matheus A Moreira; Nathália C L Evangelista; Rafael S Maior; Marilia Barros
Journal:  Anim Cogn       Date:  2022-10-01       Impact factor: 2.899

2.  Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects.

Authors:  Gunter Schumann; Johannes Kornhuber; Christian P Müller; Liubov S Kalinichenko; Christiane Mühle; Tianye Jia; Felix Anderheiden; Maria Datz; Anna-Lisa Eberle; Volker Eulenburg; Jonas Granzow; Martin Hofer; Julia Hohenschild; Sabine E Huber; Stefanie Kämpf; Georgios Kogias; Laura Lacatusu; Charlotte Lugmair; Stephen Mbu Taku; Doris Meixner; Nina Tesch; Marc Praetner; Cosima Rhein; Christina Sauer; Jessica Scholz; Franziska Ulrich; Florian Valenta; Esther Weigand; Markus Werner; Nicole Tay; Conor J Mc Veigh; Jana Haase; An-Li Wang; Laila Abdel-Hafiz; Joseph P Huston; Irena Smaga; Malgorzata Frankowska; Malgorzata Filip; Anbarasu Lourdusamy; Philipp Kirchner; Arif B Ekici; Lena M Marx; Neeraja Puliparambil Suresh; Renato Frischknecht; Anna Fejtova; Essa M Saied; Christoph Arenz; Aline Bozec; Isabel Wank; Silke Kreitz; Andreas Hess; Tobias Bäuerle; Maria Dolores Ledesma; Daniel N Mitroi; André M Miranda; Tiago G Oliveira; Erich Gulbins; Bernd Lenz
Journal:  Mol Psychiatry       Date:  2021-09-28       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.